High-Throughput Screening (HTS)
Integrated hit identification using HTS, fragment screening, and advanced automation delivering high-quality starting points for successful drug discovery.
Explore capabilityTarget validation, screening, assay development, and preclinical biology to advance your discovery program.
The science
We provide in-vitro and in-vivo biology services that can be accessed as stand-alone offerings or incorporated into fully integrated drug discovery programs. For each project, we tailor study design to program needs and deliver decision-ready data with short turnaround times. Our biology services span a broad range of target classes, modalities, and therapeutic areas, including oncology, immunology, inflammation, metabolic disease, cardiovascular disease, and neurodegenerative disorders.
How we can help
Explore the services and methods available for your project.
Integrated hit identification using HTS, fragment screening, and advanced automation delivering high-quality starting points for successful drug discovery.
Explore capabilityTailored cell-based assays for target validation, compound profiling, and mechanism studies delivering robust, physiologically relevant data to guide discovery.
Explore capabilityCustom assay solutions built around your biology delivering reliable, decision-ready data to advance hit finding and compound profiling with confidence.
Explore capabilityCustom biochemical and biophysical assays built around your target biology, from enzyme activity to binding kinetics and target engagement, providing robust, high-quality data to guide hit identification and mechanism-of-action studies.
Explore capabilityPreclinical in-vivo pharmacology services with tailored study design, meaningful endpoints, and a clear path forward.
Explore capabilityHow a project runs
4 stages, with a clear outcome at each step.
Collaborating closely on study design, incorporating meaningful endpoints, target selection, and customized assay protocols.
Outcome: Tailored Strategy
Developing custom biochemical and cell-based assays, executing High Throughput Screening (HTS) and fragment screening.
Outcome: High-Quality Hits
Conducting high-throughput biophysical binding kinetics, cell-based mechanism studies, and target engagement evaluations.
Outcome: Target Engagement
Executing preclinical in-vivo pharmacology with close collaboration across Chemistry R&D, Bioanalytical, and DMPK teams.
Outcome: Decision-Ready Data
Explore in detail
Open a section to explore our full service scope and instrumentation.
Let’s work together
Talk with our scientific team about your requirements,
technical feasibility, and timelines.